Completed
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001
NCT05121831
- Conditions
- Depressive Disorder, Mental Disorders, Mood Disorders
- Locations
-
- CMAX Clinical Research Address Adelaide, South Australia, Australia